Delivery Order SPE2DB22D2007-SPE2DB25FJ3FP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,363.52 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $12,415.02 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $32,589.17 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's demonstrated capability to compete for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at approximately $4.95K to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units. The contract employs firm fixed pricing and carries a completion date of July 31, 2025. This non-set-aside competitive award reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor within the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,005.35 on August 15, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,264.85 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order represents a single transaction within AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is...
- The Defense Logistics Agency awarded a $2,205.36 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% patches (30-count). This competitively awarded, firm fixed price contract is scheduled for completion by August 18, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3FPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,111.65 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's prime IDC with the DLA valued at approximately $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's federal procurement portfolio demonstrates extensive capability in delivering both brand-name and generic medications, specialized therapeutics, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/22/25 |